May 11, 2026 08:30AM
Apr 27, 2026 08:47AM
Apr 27, 2026 08:47AM
Apr 22, 2026 09:35AM
Apr 22, 2026 09:35AM
Mar 24, 2026 09:07AM
Mar 6, 2026 08:00AM Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
Feb 23, 2026 08:31AM
Feb 23, 2026 08:30AM
Feb 4, 2026 09:35AM
Nov 14, 2025 08:30AM
Oct 9, 2025 08:32AM
Oct 9, 2025 08:30AM
Sep 16, 2025 08:00AM Adial Pharmaceuticals receives FDA feedback on AD04 phase 3 trial design
Sep 16, 2025 08:00AM
Aug 20, 2025 08:31AM
Aug 20, 2025 08:30AM
Aug 14, 2025 08:30AM
Aug 6, 2025 08:02AM
Aug 6, 2025 08:00AM
Jul 9, 2025 08:32AM Adial Pharmaceuticals files patent application for AD04 drug through 2045
Jul 9, 2025 08:30AM
Jun 25, 2025 08:35AM
Jun 25, 2025 08:30AM
Jun 16, 2025 08:00AM
May 15, 2025 08:30AM
May 8, 2025 08:30AM
May 8, 2025 08:30AM Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration
Mar 4, 2025 08:30AM
Feb 25, 2025 09:01AM
Feb 25, 2025 09:00AM
Jan 29, 2025 09:02AM
Jan 29, 2025 09:00AM
Nov 14, 2024 08:40AM
Nov 14, 2024 08:30AM Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Nov 13, 2024 08:30AM
Sep 19, 2024 08:31AM
Sep 19, 2024 08:30AM
Sep 4, 2024 09:00AM
Aug 14, 2024 08:30AM
Aug 13, 2024 09:03AM
Aug 13, 2024 09:00AM Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04
Aug 7, 2024 09:00AM
Jul 23, 2024 08:30AM
Jun 5, 2024 08:31AM
Jun 5, 2024 08:30AM
May 15, 2024 08:30AM
Nov 14, 2023 05:02PM
Oct 25, 2023 08:00AM Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar
Aug 21, 2023 08:30AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All